Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA279840
Max Phase: Preclinical
Molecular Formula: C10H17N2O8P
Molecular Weight: 324.23
Molecule Type: Small molecule
Associated Items:
ID: ALA279840
Max Phase: Preclinical
Molecular Formula: C10H17N2O8P
Molecular Weight: 324.23
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cn(COC(CP(=O)(O)O)C(O)CO)c(=O)[nH]c1=O
Standard InChI: InChI=1S/C10H17N2O8P/c1-6-2-12(10(16)11-9(6)15)5-20-8(7(14)3-13)4-21(17,18)19/h2,7-8,13-14H,3-5H2,1H3,(H,11,15,16)(H2,17,18,19)
Standard InChI Key: AKTOMHJHOYJVRE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 324.23 | Molecular Weight (Monoisotopic): 324.0723 | AlogP: -2.28 | #Rotatable Bonds: 7 |
Polar Surface Area: 162.08 | Molecular Species: ACID | HBA: 7 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 10 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 1.77 | CX Basic pKa: | CX LogP: -2.56 | CX LogD: -4.92 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.35 | Np Likeness Score: 0.21 |
1. Racha S, Vargeese C, Vemishetti P, El-Subbagh HI, Abushanab E, Panzica RP.. (1996) Synthesis and biological evaluation of1',2'-seconucleo-5'- phosphonates., 39 (5): [PMID:8676349] [10.1021/jm9506783] |
Source(1):